[P1] Poster Session Core Time (奇数番号)

R&D IIIImmunology

[P1-5] Prime-Push Mtb Vaccination Drives Immuno-Switching in the Tumor Microenvironment

*Burcu Temizoz^1,2,6,7, Nobuyoshi Kobayashi^3,2, Yuta Ohira^3,2, Areej S¹, Kou Hioki¹, Mai Onaga¹, Tomoya Hayashi^1,2,6,7, Michelle Sue Jann Lee⁵, Takayuki Horii³, Cevayir Coban^5,4,7,6, Kouji Kobiyama^1,6,8, Ken J. Ishii^1,2,4,6,7 (1. Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 2. Center for Adjuvant and Vaccine Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8, Osaka, Japan (Japan), 3. Central Research Laboratories, Zeria Pharmaceutical Co., Ltd., 2512-1 Numagami, Oshikiri, Kumagaya-shi, Saitama, Japan (Japan), 4. WPI Immunology Frontier Research Center (IFReC), Osaka University, 3-3-1, Osaka, Japan (Japan), 5. Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1, Tokyo, Japan (Japan), 6. International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1, Tokyo, Japan (Japan), 7. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan. (Japan), 8. Division of Rheumatology, Department of Medicine, University of California San Diego, La Jolla (USA))

閲覧にはパスワードが必要です

ログイン

または